•
TW
TWST
Twist Bioscience Corporation Common Stock
yahooBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
--
Price Chart
Market Cap
2.67B
Volume
1.11M
52W High
$55.33
52W Low
$23.30
Open
$0.00
Prev Close
$41.65
Day Range
0.00 - 0.00
About Twist Bioscience Corporation Common Stock
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
Latest News
DNA Computing Market - Global Forecast 2025-2032
GlobeNewswire Inc.•Dec 12
Cell Culture Microcarriers Market Size Leads at 8.54% CAGR by 2034 – Towards Healthcare
GlobeNewswire Inc.•Dec 1
DNA Data Storage Market to Reach $3348 Million by 2030, Transforming the Future of Data Archiving
GlobeNewswire Inc.•Aug 22
Twist Bioscience (TWST) Q3 Profit Surges
The Motley Fool•Aug 4
Global Antibody Discovery Market to Observe Stupendous Growth at a CAGR of ~10% by 2032 | DelveInsight
GlobeNewswire Inc.•Jul 30
U.S. Minimal Residual Disease Testing Market Trends Analysis Report 2025-2033 | Integration with Personalized Medicines, & Rising Incidence and Prevalence of Hematological Malignancies Fueling Growth
GlobeNewswire Inc.•Jul 25
Antibody Discovery Market Size to Achieve USD 22,570 Mn by 2034 | Statifacts
GlobeNewswire Inc.•Apr 11
RNA Transcriptome Profiling Tests Market Expands at 14.5% CAGR, Surpassing US$ 37 Billion by 2034 | Fact.MR Report
GlobeNewswire Inc.•Jan 20